The Purkinje cell antibody (PCA) test is a vital diagnostic tool used to detect specific autoantibodies in the serum or cerebrospinal fluid (CSF) of patients, aiding in the diagnosis of paraneoplastic neurological disorders (PNDs). These disorders occur when the immune system mistakenly attacks the nervous system in response to cancer, often linked to ovarian, breast, and small-cell lung carcinomas. The test identifies two main types of autoantibodies: PCA-1 (anti-Yo), associated with gynecologic cancers and cerebellar degeneration, and PCA-2, linked to small-cell lung carcinoma. By detecting these autoantibodies, the PCA test helps uncover underlying malignancies that might not be evident through standard diagnostic methods. This early detection is crucial for managing neurological symptoms and initiating appropriate cancer treatment. The test employs indirect immunofluorescence assays, ensuring accurate identification of autoantibodies, and provides essential insights into the patient's immune response, guiding further clinical investigations and interventions.
The Purkinje cell antibody (PCA) test is a vital diagnostic tool used to detect specific autoantibodies in the serum or cerebrospinal fluid (CSF) of patients, aiding in the diagnosis of paraneoplastic neurological disorders (PNDs). These disorders occur when the immune system mistakenly attacks the nervous system in response to cancer, often linked to ovarian, breast, and small-cell lung carcinomas. The test identifies two main types of autoantibodies: PCA-1 (anti-Yo), associated with gynecologic cancers and cerebellar degeneration, and PCA-2, linked to small-cell lung carcinoma. By detecting these autoantibodies, the PCA test helps uncover underlying malignancies that might not be evident through standard diagnostic methods. This early detection is crucial for managing neurological symptoms and initiating appropriate cancer treatment. The test employs indirect immunofluorescence assays, ensuring accurate identification of autoantibodies, and provides essential insights into the patient's immune response, guiding further clinical investigations and interventions.
The lowest price from the last 30 days: £34
Awaiting result:
One day
Collect material:
Blood
Prepare:
The Purkinje cell antibody (PCA) test is essential for diagnosing paraneoplastic neurological disorders (PNDs) by detecting PCA-1 and PCA-2 autoantibodies. These antibodies are linked to cancers like ovarian, breast, and small-cell lung carcinomas. Key objectives include:
- Diagnosis: Identify PNDs by detecting PCA-1 (anti-Yo) and PCA-2 autoantibodies.
- Cancer Detection: Reveal underlying malignancies not visible through standard imaging.
- Clinical Management: Guide treatment decisions for neurological symptoms and associated cancers.
- Specimen Handling: Ensure proper collection and storage of serum and CSF samples for accurate results.
The Pear IgE serum test is essential for diagnosing pear allergies by detecting specific IgE antibodies. Key points include:
- Purpose: Identifies pear allergens causing allergic reactions, crucial for diagnosis and management.
- Methodology: Utilizes ImmunoCAP FEIA, involving serum collection, allergen binding, and fluorescence measurement.
- Interpretation:
- Positive: Indicates sensitization to pear.
- Negative: Suggests lower likelihood of sensitization.
- Clinical Relevance: Aids in allergy diagnosis, immunotherapy preparation, and managing allergic reactions.
- Specimen Handling: Proper storage and handling ensure accurate results.
- Turnaround: Results typically available in 2-4 days.
Understanding test results for the Purkinje cell antibody (PCA) test is crucial for diagnosing paraneoplastic neurological disorders (PNDs). Here's a brief overview:
- Purpose: Identifies autoantibodies linked to neurological disorders triggered by cancers like ovarian, breast, and small-cell lung carcinomas.
- Types: PCA-1 (anti-Yo) and PCA-2.
- Clinical Significance: Presence of PCA-1 or PCA-2 suggests an immune response to specific cancers.
- Diagnostic Steps:
1. Initial screening with serum or CSF samples.
2. Reflex testing for specific autoantibody type.
3. Interpretation in context of symptoms and cancer risk factors.
The lowest price from the last 30 days: £34
What is GetLabTest.com?
How do I get started with GetLabTest.com?
What diseases can GetLabTest.com detect?
How do I prepare for testing with GetLabTest.com?
Can I speak with a doctor about my results?
Is testing with GetLabTest.com covered by insurance?
How long does it take to receive the test results?
Can I access my test results online?
Is my personal information kept confidential?
What if I have questions or concerns about my test results?